Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers.

Li, Bryan; Yau, Thomas; Leung, Roland; Kwok, Gerry; Tsang, Josephine; Cheung, Polly; Wong, T T; Suen, Dacita; Kwong, Ava; Chiu, Joanne W

Li, Bryan; Yau, Thomas; Leung, Roland; Kwok, Gerry; Tsang, Josephine; Cheung, Polly; Wong, T T; Suen, Dacita; Kwong, Ava; Chiu, Joanne W.

Afiliação

Li B; Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Yau T; Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Leung R; Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Kwok G; Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Tsang J; Division of Hematology and Medical Oncology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Cheung P; Department of Surgery, Hong Kong Sanatorium Hospital, Happy Valley, Hong Kong.
Wong TT; Department of Surgery, Hong Kong Sanatorium Hospital, Happy Valley, Hong Kong.
Suen D; Department of Surgery, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
Kwong A; Department of Surgery, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
Chiu JW; Department of Surgery, Hong Kong Sanatorium Hospital, Happy Valley, Hong Kong.

Adv Ther ; 38(12): 5752-5762, 2021 12.

Article em En | MEDLINE | ID: mdl-34699004

Assuntos

Neoplasias da Mama; Neoplasias de Mama Triplo Negativas; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Ciclofosfamida/uso terapêutico; Docetaxel/uso terapêutico; Epirubicina; Feminino; Humanos; Terapia Neoadjuvante; Receptor ErbB-2/uso terapêutico; Resultado do Tratamento; Neoplasias de Mama Triplo Negativas/tratamento farmacológico

Palavras-chave

Anthracycline; Breast cancer; Neoadjuvant therapy; Pathologic complete response; TEC; Taxane

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google